-
If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Site Members can sign up for company wide alerts
Lawsuit Overview
<p>The complaint alleges that during the Class Period defendants violated the federal securities laws by issuing a series of materially false and misleading statements to the market about the Company and by failing to disclose material information about the Company’s plan to merge with Genzyme and that when the market learned the truth, the price of Bioenvision securities increa...
You must register (for free) or login to view the entire case.